• English
  • 简体中文
Login Register
Current Location: Home > Feedback Help Print

【结 构 式】

【分子编号】10010

【品名】o-Cresol

【CA登记号】95-48-7

【 分 子 式 】C7H8O

【 分 子 量 】108.13992

【元素组成】C 77.75% H 7.46% O 14.8%

与该中间体有关的原料药合成路线共 6 条

合成路线1

该中间体在本合成路线中的序号:(VII)

A new synthesis for tomoxetine hydrochloride has been reported: The reduction of benzoylacetic acid ethyl ester (I) with Baker's yeast and glucose in water, or the enzymatic hydrolysis of 3-acetoxy-3-phenylpropionic acid ethyl ester (II), gives (-)-3-hydroxy-3-phenylpropionic acid ethyl ester (III), which by reaction with methylamine yields the corresponding amide (IV). The reduction of (IV) with LiAlH4 in ether affords (-)-3-hydroxy-N-methyl-3-phenylpropylamine (V), which is protected with di-tert-butyldicarbonate to the amide (VI). The condensation of (VI) with o-cresol (VII) by means of triphenylphosphine and diethylazodicarboxylate (DEAD) in ether yields the protected final product (VIII), which is finally deprotected with dry HCl in methanol.

1 Dike, S.Y.; Kumar, A.; Ner, D.H.; A new chemoenzymatic enantioselective synthesis of R-(-)-tomoxetine, (R)-fluoxetine and (S)-fluoxetine. Tetrahedron Lett 1991, 32, 16, 1901.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 10004 Ethyl 3-oxo-3-phenylpropanoate; Benzoylacetic acid, ethyl ester 94-02-0 C11H12O3 详情 详情
(II) 10005 Ethyl 3-(acetoxy)-3-phenylpropanoate C13H16O4 详情 详情
(III) 10006 Ethyl (3S)-3-hydroxy-3-phenylpropanoate; (-)-Ethyl (S)-3-hydroxy-3-phenylpropionate 33401-74-0 C11H14O3 详情 详情
(IV) 10007 (3S)-3-Hydroxy-N-methyl-3-phenylpropanamide C10H13NO2 详情 详情
(V) 10008 (1S)-3-(Methylamino)-1-phenyl-1-propanol 114133-37-8 C10H15NO 详情 详情
(VI) 10009 tert-Butyl N-[(3S)-3-hydroxy-3-phenylpropyl]-N-methylcarbamate C15H23NO3 详情 详情
(VII) 10010 o-Cresol 95-48-7 C7H8O 详情 详情
(VIII) 10011 tert-Butyl N-methyl-N-[(3R,4E,6Z)-3-(2-methylphenoxy)-4-vinyl-4,6-octadienyl]carbamate C22H29NO3 详情 详情

合成路线2

该中间体在本合成路线中的序号:(V)

A new synthesis of tomoxetine has been described: The reduction of omega-chloropropiophenone (I) with NaBH4 in ethanol gives 3-chloro-1-phenyl-1-propanol (II), which is treated with butyric anhydride and pyridine in dichloromethane to yield the corresponding racemic ester (III). The optical resolution of (III) with immobilized lipase B from Candida antarctica (CALB) affords a mixture of unreacted (S)-ester and (R)-alcohol (IV) that are separated by column chromatography. Condensation of th (R)-alcohol (IV) with 2-methylphenol (V) by means of PPh3 and diethyl azodicarboxylate (DEAD) in THF gives the corresponding ether (VI), which is finally treated with methylamine in refluxing ethanol.

1 Anthonsen, T.; Ho, B.H.; Liu, H.L.; Chemoenzymatic synthesis of the non-tricyclic antidepressants fluoxetine, tomoxetine and nisoxetine. J Chem Soc - Perkins Trans I 2000, 11, 11, 1767.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 28073 3-chloro-1-phenyl-1-propanone 936-59-4 C9H9ClO 详情 详情
(II) 28074 3-chloro-1-phenyl-1-propanol C9H11ClO 详情 详情
(III) 37781 3-chloro-1-phenylpropyl butyrate C13H17ClO2 详情 详情
(IV) 37782 (1R)-3-chloro-1-phenyl-1-propanol C9H11ClO 详情 详情
(V) 10010 o-Cresol 95-48-7 C7H8O 详情 详情
(VI) 44328 (1R)-3-chloro-1-phenylpropyl 2-methylphenyl ether; 1-[[(1R)-3-chloro-1-phenylpropyl]oxy]-2-methylbenzene 114446-47-8 C16H17ClO 详情 详情

合成路线3

该中间体在本合成路线中的序号:(VII)

The reduction of 3-hydroxy-3-phenylpropionic acid ethyl ester (I) with LiAlH4 in THF gives 1-phenylpropane-1,3-diol (II), which is treated with Ts-Cl and TEA in dichloromethane to yield the monotosylate (III). The optical resolution of (III) by means of (Pd(OAc)2, (-)-sparteine and O2 in hot toluene yields a mixture of the desired (S)-1-phenyl-3-(tosyloxy)-1-propanol (IV) and the propiophenone (V) that is separated by column chromatography. The reaction of (IV) with methylamine in hot THF affords the chiral secondary amine (VI), which is finally condensed with 2-methylphenol (VII) by means of PPh3 and DEAD in ethyl ether to provide the target (R)-tomoxetine.

1 Ali, I.S.; Sudalai, A.; Pd-catalyzed kinetic resolution of benzylic alcohols: A practical synthesis of (R)-tomoxetine and (S)-fluoxetine hydrochlorides. Tetrahedron Lett 2002, 43, 31, 5435.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 57231 Ethyl beta-hydroxyhydrocinnamate C11H14O3 详情 详情
(II) 57227 1-Phenyl-1,3-propanediol C9H12O2 详情 详情
(III) 57228 3-hydroxy-3-phenylpropyl 4-methylbenzenesulfonate C16H18O4S 详情 详情
(IV) 57229 (3S)-3-hydroxy-3-phenylpropyl 4-methylbenzenesulfonate C16H18O4S 详情 详情
(V) 57230 3-oxo-3-phenylpropyl 4-methylbenzenesulfonate C16H16O4S 详情 详情
(VI) 10008 (1S)-3-(Methylamino)-1-phenyl-1-propanol 114133-37-8 C10H15NO 详情 详情
(VII) 10010 o-Cresol 95-48-7 C7H8O 详情 详情

合成路线4

该中间体在本合成路线中的序号:(V)

The asymmetric epoxidation of (E)-3-phenyl-2-propen-1-ol (I) by means of titanium tetraisopropoxide, (+)-diethyl tartrate (+)-(DET) and tBu-OOH in dichloromethane gives the chiral epoxide (II), which is opened by means of bis(2-methoxyethoxy)aluminum hydride (Red-Al) in DME to yield the chiral diol (III). The regioselective reaction of (III) with Ms-Cl and TEA in ethyl ether affords the primary mesylate (IV), which is condensed with 2-methylphenol (V) by means of PPh3 and DEAD in ethyl ether to provide the adduct (VI). Finally this compound is treated with methylamine in hot aq. THF to give rise to the target (R)-tomoxetine.

1 Gao, Y.; et al.; Catalytic asymmetric epoxidation and kinetic resolution: Modified procedures including in situ derivatization. J Am Chem Soc 1987, 109, 19, 5765.
2 Gao, Y.; Sharpless, K.B.; Asymmetric synthesis of both enantiomers of tomoxetine and fluoxetine. Selective reduction of 2,3-epoxycinnamyl alcohol with Red-Al. J Org Chem 1988, 53, 17, 4081.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 13951 (E)-3-Phenyl-2-propen-1-ol 104-54-1 C9H10O 详情 详情
(II) 57232 (2R,3R)-3-Phenyl glycidol 98819-68-2 C9H10O2 详情 详情
(III) 57233 (S)-1-Phenyl-1,3-propanediol; (S)-3-Phenyl-1,3-propanediol 96854-34-1 C9H12O2 详情 详情
(IV) 57234 (3S)-3-hydroxy-3-phenylpropyl methanesulfonate C10H14O4S 详情 详情
(V) 10010 o-Cresol 95-48-7 C7H8O 详情 详情
(VI) 57235 (3R)-3-(2-methylphenoxy)-3-phenylpropyl methanesulfonate C17H20O4S 详情 详情

合成路线5

该中间体在本合成路线中的序号:(A)

The 5-methylsalicylaldehyde (I) is prepared by a tin (IV) chloride-catalyzed formylation. Iodination of the aldehyde with ICl in glacial acetic acid gives good yield of 3-methyl-5-iodobenzylaldehyde (III). The iodinated salicylaldehyde is reductively aminated with N,N,N'-trimethylpropane-1,3-diamine and sodium borohydride to give N,N,N'-trimethyl-N'-(2-hydroxy-3-methyl-5-iodobenzyl)-1,3-propanediamine (HIPDM) (III) in excellent yield.

1 Blau, M.; Tramposch, K.M.; Kung, H.F.; Radioiodine-labeled N,N-dimethyl-N'-(2-hydroxy-3-ankyl-5-iodobenzyl)-1,3.propanediamines for Brain Perfusion Imaging. J Med Chem 1983, 28, 2, 121-125.
2 Kung, H.F.; Hostyniak, P.J.; HIPDM. Drugs Fut 1985, 10, 9, 742.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(A) 10010 o-Cresol 95-48-7 C7H8O 详情 详情
(I) 28163 2-hydroxy-3-methylbenzaldehyde C8H8O2 详情 详情
(II) 28164 2-hydroxy-5-iodo-3-methylbenzaldehyde C8H7IO2 详情 详情
(III) 28165 N-[3-(dimethylamino)propyl]-N-methylamine 4543-96-8 C6H16N2 详情 详情

合成路线6

该中间体在本合成路线中的序号:(I)

 

1 Brown HC 1989. Novel process of producing phenyl or substituted phenylalkylanune pharmaceutical agents and novel chiral intermediatesof high enantiomeric purity useful therein US 4868344
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 10010 o-Cresol 95-48-7 C7H8O 详情 详情
(II) 37782 (1R)-3-chloro-1-phenyl-1-propanol C9H11ClO 详情 详情
(III) 66135 (S)-(3-chloro-1-phenoxypropyl)benzene   C15H15ClO 详情 详情
Extended Information